AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 9.34 Real-Time Quote |  -0.26 / -2.71%Today’s Change | 2.27 Today|||52-Week Range 10.59 | +119.25% Year-to-Date |
Latest ACRX News | Press Releases
No recent news for AcelRx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 9.60 |
| Today’s open | 9.55 |
| Day’s range | 9.26 - 9.68 |
| Volume | 203,588 |
| Average volume (3 months) | 436,912 |
| Market cap | $357.5M |
| Dividend yield | -- |
Data as of 3:25pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -30.17% |
| Earnings growth (this year) | +34.88% |
| Earnings growth (next 5 years) | +79.70% |
| Revenue growth (last year) | +123.32% |
| P/E ratio | NM |
| Price/Sales | 39.37 |
| Price/Book | 10.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RPRXRepros Therapeutics ... | -0.01 | -0.05% |
| RGLSRegulus Therapeutics... | +0.05 | +0.51% |
| LCILannett Company Inc | -0.44 | -3.63% |
| FURXFuriex Pharmaceutica... | -1.13 | -3.05% |
Data as of 3:26pm ET, 06/19/2013
Financials
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$33.4M |
| Net profit margin | -1,393.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Richard A. King, MBA |
Vice President- Business Operations Carter J. King, MBA |
Corporate headquarters Redwood City, California |
Forecasts
